1.Reversal of Multidrug Resistance by IFN-? in KBv200 Cell Lines
Yan LIANG ; Xiyin WEI ; Kai LI ; Yi YANG ; Ruifang NIU
Chinese Journal of Cancer Biotherapy 1995;0(03):-
Objective: To explore the effects of various concentrations IFN-? on human oral epidermic cancer cell line KB and its multidrug resistant counterpart KBv200.Methods: The toxicity of IFN-? and/or VCR was assayed by MTT method; intracellular rhodamin123 concentration and p-glycoprotein expression were measured by flow cytometry; mdr-1 mRNA was assayed by RT-PCR. Results: High-dose IFN-?(10 000 IU/ml) had significant antiproliferative effects on KB/KBv200 cell lines. Low-dose IFN-? did not have any significant effect on growth of KB/KBv200 cells, but did increase the cytotoxic effect of VCR and the accumulation of Rhodamine123 in KBv200 cell line and had no effect on parent VCR-sensitive KB cell line. IFN-? down-regulated expression of P-gp and mdr-1mRNA . Conclusions: IFN-? has significant effect on the reversal of multidrug resistance of KBv200 cell line via a mechanism of P-gp and mdr1 mRNA down-regulation.
2.FAN Wenhu 's Experience in Treating Dampness Prevalent Diseases with Flexible Use of Wetting Method
Xiyin YANG ; Yu BAI ; Yongcan CHEN
Journal of Zhejiang Chinese Medical University 2017;41(12):965-966
[Objective]Analysis of the famous doctor FAN Wenhu treatment of dampness prevalent diseases experience with a view to the clinical treatment of it to provide reference.[Methods]By consulting the relevant FAN Wenhu's medical information and screening out the treatment of dampness prevalent diseases of his cases to further analyze and sum up his clinical experience in the treatment of it. [Result] It was found out that he was skilled in using wetting treatments for dampness prevalent diseases, which the wet wilt in the upper body used Qingzhen decoction to clear dampness wetting,the vomid malaria used Huopusini powder to regulate qi and dispel wet, the damp-heat invagination used Huopuwuling powder to activate yang to remove dampness. [Conclusion]FAN Wenhu was flexibled to use varieties of dampness methods in the treatment of dampness prevalent disease in order to eliminate wet evil and isolate hot evil.These cases had accurate effect and distinct treatment characteristics,it is worthy of reference.
3.Efficacy and safety of enteral nutrition in preoperative bowel preparation for colorectal cancer: a meta-analysis
Qiang HU ; Xiyin YANG ; Yuanshui SUN ; Fengyong WANG
Chinese Journal of Clinical Nutrition 2018;26(1):26-33
Objective To systematically evaluate the efficacy and safety of enteral nutrition in preoperative bowel preparation for colorectal cancer.Methods We searched in multiple databases (i.e.CNKI,Wanfang Data,VIP,PubMed,Coehrane Library,and Web of Science) for studies up to March 2017 that compared the efficacy and safety of enteral nutrition vs.mechanical bowel preparation before surgical treatment of colorectal cancer.Meta-analysis was conducted with RevMan 5.3 to compare the two approaches in terms of postoperative lymphocyte count,complications,anal exhaust time,intestinal cleaning rate,and levels of prealbumin,albumin,hemoglobin,and transferrin.Results A total of 12 randomized controlled trials involving 617 patients were included in this study,where 308 patients received enteral nutrition and 309 had mechanical bowel preparation.The results showed that enteral nutrition was comparable to mechanical bowel preparation in bowel cleaning rate (OR =1.54,95% CI=0.98-2.41,P=0.06) and anal exhaust time (WMD =-8.14,95% CI=-18.25-2.07,P=0.12),and it could lead to higher levels of lymphocytes (WMD=0.19,95% CI=0.06-0.32,P<0.01),prealbumin (WMD=20.16,95% CI=15.77-20.54,P<0.01),albumin (WMD =2.60,95% CI=1.69-3.51,P<0.01),hemoglobin (WMD=7.18,95% CI=3.61-10.75,P<0.01),and transferrin (WMD=0.29,95% CI=0.12-0.47,P<0.01),and reduce the incidence of postoperative complications (OR=0.18,95% CI=0.11-0.28,P<0.01).Conclusions Current evidence showed that using enteral nutrition for bowel preparation before surgical treatment of colorectal cancer could improve postoperative profiles of lymphocyte count,prealbumin,albumin,hemoglobin,and transferrin,and reduce complications.This approach should be adopted in the clinic.
4.Preliminary study of pencil beam scanning proton and carbon ion therapy for chordoma and chondrosarcoma of head and neck
Xiyin GUAN ; Jing GAO ; Jiyi HU ; Weixu HU ; Jing YANG ; Youqi YANG ; Tingting XU ; Chaosu HU ; Jiade LU ; Lin KONG
Chinese Journal of Radiation Oncology 2018;27(10):886-889
Objective To evaluate the short-term efficacy and adverse events of pencil beam scanning proton and carbon ion therapy in the treatment of chordoma and chondrosarcoma of the head and neck.Methods Between July 2014 and July 31,2017,61 patients with chordoma and chondrosarcoma of the head and neck receiving proton and heavy ion therapy as the first course of radiotherapy were enrolled.Among them,45 patients were diagnosed with chordoma and 16 cases of chondrosarcoma,39 male and 22 female.The median age was 38 years old (range:14-70 years).The median maximum tumor diameter was 4.1 cm (range:0-8.6 cm).The clivus and the cervical spine were the primary tumor sites.Results Eight patients received proton therapy,21 patients were treated with proton combined with carbon ion therapy and 32 patients received carbon ion therapy.All patients successfully completed the planned radiotherapy.The medial follow-up time was 21 months (range:7-47 months).No grade 3-4 acute toxicity was observed.Only one patient suffered from radiation-induced temporal lobe injury.The 2-year progression-free survival (PFS)and overall survival (OS) were 91% and 100%.Conclusions Pencil beam scanning proton and heavy ion therapy yields relatively favorable short-term outcomes in the treatment of chordoma and chondrosarcoma of the head and neck.Nevertheless,the long-term clinical efficacy and safety remain to be investigated during follow-up.
5.The preliminary result of proton and carbon ion therapy for recurrent chordoma and chondrosarcoma of skull base and cervical spine
Xiyin GUAN ; Jing GAO ; Jiyi HU ; Weixu HU ; Jing YANG ; Chaosu HU ; Lin KONG ; Jiade LU
Chinese Journal of Radiological Medicine and Protection 2020;40(6):434-438
Objective:To evaluate the short-term tumor control and toxicity of recurrent skull base and cervical spine chordoma and chondrosarcoma in patients treated with pencil beam scanning proton and heavy ion therapy.Methods:Between June 30 th, 2014 and July 30 th, 2018, a total of 45 skull base and cervical spine chordoma ( n=39) and chondrosarcoma ( n=6) patients (28 males and 17 females; mean age at initial presentation of 44 years, range, 14-76 years) were treated in our center for the course of radiotherapy. The median maximum tumor volume was 57 cm 3 (range, 6.6-231.7 cm 3). There were 31 post-operative recurrent patients and 14 post-operative and post-radiated recurrent patients. One patient received proton therapy, 21 patients received combined proton and carbon ion therapy, 23 patients received carbon ion therapy. Results:All patients completed the whole course of the treatment. The median follow-up time was 29 months (range: 8-57 months), the 2-year overall survival (OS), local control (LC), and progression-free survival (PFS) were 82.7%, 85.3%, and 73.8%, respectively. There were no other grade 3-4 acute or late radiation-induced toxicity except one grade 3 acute mucositis. The 2-year OS rates for patients after first-time radiation vs. re-irradiation were 96.2% and 50.3% ( χ2=16.969, P<0.05). Conclusions:The short-term outcomes of pencil beam scanning proton and heavy ion therapy for recurrent skull base and cervical spine chordoma and chondrosarcoma is favorable. Further study is needed for long-term efficacy and safety.
6.Preliminary study of intensity-modulated carbon ion reirradiation for locoregionally recurrent nasopharyngeal carcinoma after definitive IMRT——Clinical experience from Shanghai Proton Heavy Ion Hospital
Jiyi HU ; Jing GAO ; Weixu HU ; Jing YANG ; Xiyin GUAN ; Xianxin QIU ; Lin KONG ; Jiade LU
Chinese Journal of Radiation Oncology 2020;29(3):161-165
Objective To evaluate the short-term efficacy and toxicities of intensity-modulated carbon ion radiotherapy (IMCT) for patients with locoregionally recurrent nasopharyngeal carcinoma after intensity-modulated radiotherapy (IMRT).Methods A total of 112 patients with locoregionally recurrent nasopharyngeal carcinoma undergoing salvaging IMCT between May 2015 and February 2018were enrolled in the study.All patients previously received one course of definitive X-ray IMRT.Among them,10 patients (9%) were diagnosed with stage Ⅰ,26 patients (23%) with stage Ⅱ,41 patients (37%) with stage Ⅲ and 35 patients (31%) with stage Ⅳnasopharyngeal carcinoma,respectively.The median age of the cohort was 48 years (range,17-70 years) old.The median dose to the gross tumor volume (GTV) was 60 GyE (range,50-69 GyE).Results With a median follow-up time of 20 months (range,5-45 months),20 patients died and 42 patients developed local recurrence.The 2-year overall survival (OS) and local progression-free survival (LPFS) rates were 85% and 52%.Both univariate and multivariate analyses demonstrated that stage Ⅳ disease was associated with significantly worse OS.No predictors were found for LPFS.No acute toxicity of grade 3 or higher was observed during reirradiation.Severe (grade 3 or above) late toxicities included xerostomia (n =1),hearing impairment (n =2),temporal lobe injury (n =1) and mucosal necrosis (n =19).Conclusions IMCT is an efficacious and safe treatment for patients with locoregionally recurrent nasopharyngeal carcinoma with acceptable toxicity profile.Long-term follow-up is necessary to further evaluate the long-term efficacy and late toxicities.